The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
JE Hawkes, S Visvanathan, JG Krueger - Frontiers in Immunology, 2023 - frontiersin.org
Generalized pustular psoriasis (GPP) is a rare, chronic, inflammatory skin disorder
characterized by recurrent flares associated with skin erythema, desquamation, and …
characterized by recurrent flares associated with skin erythema, desquamation, and …
Biologics for hidradenitis suppurativa: evolution of the treatment paradigm
CA Maronese, C Moltrasio, G Genovese… - Expert Review of …, 2024 - Taylor & Francis
Introduction Hidradenitis suppurativa (HS) is an autoinflammatory skin disease with a high
unmet need for effective medical management. Clinically, it is characterized by inflammatory …
unmet need for effective medical management. Clinically, it is characterized by inflammatory …
Pyoderma gangrenosum: treatment options
Pyoderma gangrenosum is a rare neutrophilic dermatosis that leads to exceedingly painful
ulcerations of the skin. Although the exact pathogenesis is not yet fully understood, various …
ulcerations of the skin. Although the exact pathogenesis is not yet fully understood, various …
JAK-STAT pathway inhibitors in dermatology
The JAK-STAT signaling pathway mediates important cellular processes such as immune
response, carcinogenesis, cell differentiation, division and death. Therefore, drugs that …
response, carcinogenesis, cell differentiation, division and death. Therefore, drugs that …
Neutrophilic dermatoses–Pathomechanistic concepts and therapeutic developments
H Bonnekoh, L Erpenbeck - JDDG: Journal der Deutschen …, 2023 - Wiley Online Library
Neutrophilic dermatoses are a group of clinically heterogeneous diseases characterized by
infiltration of neutrophils in the affected tissue. Skin symptoms comprise a spectrum of …
infiltration of neutrophils in the affected tissue. Skin symptoms comprise a spectrum of …
Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease
Pyoderma gangrenosum (PG) is a rare inflammatory skin disease classified within the
spectrum of neutrophilic dermatoses. The pathophysiology of PG is yet incompletely …
spectrum of neutrophilic dermatoses. The pathophysiology of PG is yet incompletely …
Neutrophilic and eosinophilic dermatoses associated with hematological Malignancy
CA Maronese, F Derlino, C Moltrasio… - Frontiers in …, 2024 - frontiersin.org
Cutaneous manifestations of hematologic malignancy represent both a clinical challenge for
the treating physician and a pathophysiological model for advancing the knowledge on …
the treating physician and a pathophysiological model for advancing the knowledge on …
Hidradenitis suppurativa-related autoinflammatory syndromes: an updated review on the clinics, genetics, and treatment of pyoderma gangrenosum, acne and …
CA Maronese, C Moltrasio, AV Marzano - Dermatologic Clinics, 2024 - derm.theclinics.com
Hidradenitis suppurativa (HS) is an autoinflammatory skin disorder of the terminal hair
follicle, manifesting with painful nodules, abscesses, draining tunnels, and hypertrophic …
follicle, manifesting with painful nodules, abscesses, draining tunnels, and hypertrophic …
Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and …
TK Satoh - The Journal of dermatology, 2024 - Wiley Online Library
Pyoderma gangrenosum (PG), hidradenitis suppurativa (HS), and the associated
autoinflammatory syndromes, including pyogenic arthritis, pyoderma gangrenosum, and …
autoinflammatory syndromes, including pyogenic arthritis, pyoderma gangrenosum, and …
Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review
JL Sanz-Cabanillas, F Gómez-García… - Frontiers in …, 2024 - frontiersin.org
Introduction This scoping review explores the effectiveness of IL-1 pathway inhibitors in
managing PSTPIP1-associated inflammatory diseases (PAID). These diseases are marked …
managing PSTPIP1-associated inflammatory diseases (PAID). These diseases are marked …